专利详细信息
专利号 | US2013225598A1 |
专利标题 | Stabilized Amorphous Forms of Imatinib Mesylate |
专利权人 | GONCALVES ELISABETE [CH];KALB OSKAR [CH];MUTZ MICHAEL [DE];WIRTH WOLFGANG [CH];LAKSHMAN JAY PARTHIBAN [US];NOVARTIS AG [CH]; |
发明人 | GONCALVES ELISABETE [CH];KALB OSKAR [CH];MUTZ MICHAEL [DE];WIRTH WOLFGANG [CH];LAKSHMAN JAY PARTHIBAN [US]; |
申请号 | US201313864888 |
申请日 | 2013/4/17 |
公开日 | 2013/8/29 |
优先权号 | |
IPC | A61K31/506; A61K47/02; A61K47/10; A61K47/32; A61K47/34; A61K47/38; |
专利类型 | |
法律状态查询 | 查看法律状态 |
The invention relates to the stabilized amorphous form of the methanesulfonic acid addition salt of 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-(pyridin-3-yl)-pyrimidin-2-ylamino)-pheny]-benzamide, pharmaceutical compositions such as capsules or tablets containing this form, the use of such form in diagnostic methods or, preferably, for the therapeutic treatment of warm-blooded animals, especially humans, and the use of formulation principles stabilizing the amorphous form of Imatinib mesylate as an intermediate for the preparation of pharmaceutical compositions.
没有相关的数据
没有相关的数据
暂无附图
注:除CN专利外,本系统默认提供的所有其他中文标题和摘要来自机器翻译。